Optimizing ciprofloxacin dosing in intensive care unit patients through the use of population pharmacokinetic-pharmacodynamic analysis and Monte Carlo simulations
Author(s) -
Dalia Khachman,
JeanMarie Conil,
B. Georges,
Sylvie Saivin,
Georges Houin,
PierreLouis Toutain,
Céline M. Laffont
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkr220
Subject(s) - dosing , intensive care unit , pharmacodynamics , medicine , pharmacokinetics , ciprofloxacin , intensive care , intensive care medicine , population , pharmacology , antibiotics , biology , microbiology and biotechnology , environmental health
To explore different ciprofloxacin dosage regimens for the treatment of intensive care unit (ICU) patients with respect to clinical outcome and the development of bacterial resistance for the major Gram-negative pathogens.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom